267
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Secondary Sinonasal Collision Tumor of Papillary Squamous Cell Carcinoma and Small Cell Neuroendocrine Carcinoma After Nasopharyngeal Carcinoma Radiotherapy: A Case Report and Literature Review of Sinonasal Collision Carcinomas

ORCID Icon, , ORCID Icon, , &
Pages 91-97 | Received 09 Nov 2022, Accepted 25 Jan 2023, Published online: 11 Feb 2023

References

  • Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-0
  • Lee HF, Lan JH, Chao PJ, et al. Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT. Cancer Manag Res. 2018;10:131–141. doi:10.2147/CMAR.S145713
  • Chen CL, Hsu MM. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma. Hum Pathol. 2000;31(2):227–232. doi:10.1016/s0046-8177(00)80224-5
  • Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009;91(1):4. doi:10.1016/j.radonc.2008.12.016
  • Wang Y, Li Y, Yin B, et al. Papillary squamous cell carcinoma successfully treated with bronchoscopic intratumoral injections of cisplatin and Endostar: a case report. J Int Med Res. 2021;49(9):3000605211047077. doi:10.1177/03000605211047077
  • Righi L, Volante M, Papotti M. Small-cell carcinoma of the lung: what we learned about it? Acta Cytol. 2022;66(4):257–268. doi:10.1159/000519688
  • Brennan SM, Gregory DL, Stillie A, Herschtal A, Mac Manus M, and Ball DL. Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer. 2010;116(4):888–895. doi:10.1002/cncr.24858
  • Taggar AS, Simpson R, Hao D, et al. Secondary neuroendocrine carcinoma following high-dose radiotherapy for head and neck cancer: report of two cases. Cureus. 2016;8(10):e847. doi:10.7759/cureus.847
  • Choe AR, Shim KN, Lim J, et al. A collision tumor of the esophagus: mixed squamous cell carcinoma and neuroendocrine carcinoma. Korean J Gastroenterol. 2020;75(4):207–211. doi:10.4166/kjg.2020.75.4.207
  • Yu Q, Chen YL, Zhou SH, et al. Collision carcinoma of squamous cell carcinoma and small cell neuroendocrine carcinoma of the larynx: a case report and review of the literature. World J Clin Cases. 2019;7(2):242–252. doi:10.12998/wjcc.v7.i2.242
  • Huang SF, Chuang WY, Cheng SD, Hsin LJ, Lee LY, Kao HK. A colliding maxillary sinus cancer of adenosquamous carcinoma and small cell neuroendocrine carcinoma--A case report with EGFR copy number analysis. World J Surg Oncol. 2010;8:92. doi:10.1186/1477-7819-8-92
  • Barham HP, Said S, Ramakrishnan VR. Colliding tumor of the paranasal sinus. Allergy Rhinol. 2013;4(1):e13–e16. doi:10.2500/ar.2013.4.0040
  • Kayakabe M, Takahashi K, Okamiya T, Segawa A, Oyama T, Chikamatsu K. Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: a case report. Oncol Lett. 2014;7(4):1253–1256. doi:10.3892/ol.2014.1882
  • Franchi A, Rocchetta D, Palomba A, Degli Innocenti DR, Castiglione F, Spinelli G. Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol. 2015;9(1):107–113. doi:10.1007/s12105-013-0513-5
  • Wu SH, Zhang BZ, Han L. Collision tumor of squamous cell carcinoma and neuroendocrine carcinoma in the head and neck: a case report. World J Clin Cases. 2020;8(12):2610–2616. doi:10.12998/wjcc.v8.i12.2610
  • Sugianto I, Yanagi Y, Hisatomi M, et al. Collision tumor of small cell carcinoma and squamous cell carcinoma of the maxillary sinus: case report. Mol Clin Oncol. 2022;16(5):96. doi:10.3892/mco.2022.2529
  • Day TA, Beas RA, Schlosser RJ, et al. Management of paranasal sinus malignancy. Curr Treat Options Oncol. 2005;6(1):3–18. doi:10.1007/s11864-005-0009-y
  • Lewis JS Jr. Sinonasal squamous cell carcinoma: a review with emphasis on emerging histologic subtypes and the role of human papillomavirus. Head Neck Pathol. 2016;10(1):60–67. doi:10.1007/s12105-016-0692-y
  • Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781–789. doi:10.1016/S1470-2045(10)70017-6
  • Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15(3):264–278. doi:10.1038/modpathol.3880522
  • Mete O, Wenig BM. Update from the 5th edition of the world health organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms. Head Neck Pathol. 2022;16(1):123–142. doi:10.1007/s12105-022-01435-8
  • Ohmoto A, Sato Y, Asaka R, et al. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma. Mod Pathol. 2021;34(11):1979–1989. doi:10.1038/s41379-021-00869-9
  • Sun XS, Li XY, Chen QY, Tang LQ, Mai HQ. Future of Radiotherapy in Nasopharyngeal Carcinoma. Br J Radiol. 2019;92(1102):20190209. doi:10.1259/bjr.20190209
  • Welte B, Suhr P, Bottke D, et al. Second malignancies in high-dose areas of previous tumor radiotherapy. Strahlenther Onkol. 2010;186(3):174–179. doi:10.1007/s00066-010-2050-4
  • Scardoni M, Vittoria E, Volante M, et al. Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components. Neuroendocrinology. 2014;100(4):310–316. doi:10.1159/000369071
  • Iqbal MS, Paleri V, Moor J, et al. Small cell neuroendocrine carcinoma of larynx: case series and literature review. J Laryngol Otol. 2015;129(9):910–915. doi:10.1017/S0022215115001668